Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
DementiaNeurocognitive DisordersCognitive ImpairmentCognitive DysfunctionCognitive Decline
Interventions
OTHER

Reminiscence therapy

Intervention group will receive two RT sessions per week for 13 weeks. RT sessions will last approximately 50 minutes and will be developed according to the following structure: · Welcome to the patient and reality orientation therapy (7 minutes) · Conducting the main activity of reminiscence (40 minutes) · Closure, thank you for the participation and farewell until the next session (3 minutes) Reminiscence therapy sessions will have an individual format and will be conducted by a therapist previously trained in the protocol and the principles of RT. The Reminiscence activities of each session will be carried out following the protocol proposed in the Book of the Past and the Present.

Trial Locations (13)

3050-387

Rsocialform - Geriatria, Lda., Mealhada

9900-033

Santa Casa da Misericórdia da Horta, Horta

Unknown

Santa Casa da Misericórdia de Santa Cruz das Flores, Santa Cruz das Flores

Lar Luis Soares de Sousa de Ponta Delgada, Ponta Delgada

9930-126

Santa Casa da Misericórdia de Lajes do Pico, Lajes

9950-322

Santa Casa da Misericórdia da Madalena do Pico, Madalena

9580-528

Santa Casa da Misericórdia de Vila do Porto, Vila do Porto

9850-070

Santa Casa da Misericórdia da Calheta, Calheta

9800-559

Casa de Repouso João Inácio de Sousa, Velas

9500-377

Casa do Povo de Arrifes, Arrifes

9625-320

Casa do Povo da Maia, Maia

9700-020

Santa Casa da Misericórdia de Angra do Heroísmo, Angra do Heroísmo

9760-438

Lar D. Pedro V, Praia da Vitória

All Listed Sponsors
lead

Rsocialform - Geriatria, Lda

OTHER

NCT04658394 - Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders | Biotech Hunter | Biotech Hunter